BERNARD GROSE: Open Payments
NPI 1790087187 · SAINT ALBANS, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$833 in 44 payments from 13 companies in 2025. Trend: 2023 $617 · 2024 $552 · 2025 $833
Food & beverage: $833
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 14 | $238 |
| Novo Nordisk Inc | 5 | $101 |
| ABBVIE INC. | 5 | $95 |
| Lundbeck LLC | 4 | $82 |
| Vanda Pharmaceuticals Inc. | 4 | $76 |
| Neurocrine BioSciences, Inc. | 3 | $53 |
| Axsome Therapeutics, Inc. | 2 | $47 |
| E.R. Squibb & Sons, L.L.C. | 2 | $45 |
| Hologic Sales and Service, LLC | 1 | $24 |
| Exact Sciences Corporation | 1 | $22 |
Products named: LYBALVI, VRAYLAR, REXULTI, FANAPT, INGREZZA, Auvelity, COBENFY, Ozempic.
Industry payments across WV — which companies pay providers there.
